Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
307.80 SEK | +2.98% |
|
-4.57% | -3.74% |
09:22am | Troilus Gold Agrees to Commercial Offtake Terms With Boliden for Copper-Gold Concentrate | MT |
07:32am | Troilus agrees to commercial offtake terms with Boliden for copper-gold concentrate | RE |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 56.32B | 68.64B | 86.44B | 78.55B | 89.21B | |||||
Total Revenues | 56.32B | 68.64B | 86.44B | 78.55B | 89.21B | |||||
Cost of Goods Sold, Total | 45.52B | 55.71B | 68.29B | 67.82B | 76.3B | |||||
Gross Profit | 10.8B | 12.93B | 18.15B | 10.74B | 12.9B | |||||
Selling General & Admin Expenses, Total | 1.19B | 1.15B | 1.68B | 1.84B | 2.04B | |||||
R&D Expenses | 749M | 965M | 1.05B | 1.15B | 1.14B | |||||
Other Operating Expenses | 251M | 83M | 64M | -403M | -81M | |||||
Other Operating Expenses, Total | 2.19B | 2.2B | 2.8B | 2.59B | 3.1B | |||||
Operating Income | 8.61B | 10.73B | 15.35B | 8.15B | 9.81B | |||||
Interest Expense, Total | -117M | -118M | -251M | -693M | -954M | |||||
Interest And Investment Income | 2M | 1M | 49M | 204M | 218M | |||||
Net Interest Expenses | -115M | -117M | -202M | -489M | -736M | |||||
Income (Loss) On Equity Invest. | - | - | - | -1M | - | |||||
Currency Exchange Gains (Loss) | 85M | 209M | 437M | - | 257M | |||||
Other Non Operating Income (Expenses) | -40M | -13M | -24M | -58M | -111M | |||||
EBT, Excl. Unusual Items | 8.54B | 10.81B | 15.56B | 7.6B | 9.22B | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | 23M | 6M | - | - | - | |||||
Insurance Settlements | 104M | 6M | 20M | - | 3.34B | |||||
Other Unusual Items | - | 16M | 19M | - | - | |||||
EBT, Incl. Unusual Items | 8.67B | 10.84B | 15.6B | 7.6B | 12.56B | |||||
Income Tax Expense | 1.87B | 2.14B | 3.19B | 1.53B | 2.53B | |||||
Earnings From Continuing Operations | 6.8B | 8.7B | 12.41B | 6.07B | 10.03B | |||||
Net Income to Company | 6.8B | 8.7B | 12.41B | 6.07B | 10.03B | |||||
Minority Interest | -2M | -4M | -1M | -1M | -4M | |||||
Net Income - (IS) | 6.8B | 8.7B | 12.41B | 6.07B | 10.02B | |||||
Net Income to Common Incl Extra Items | 6.8B | 8.7B | 12.41B | 6.07B | 10.02B | |||||
Net Income to Common Excl. Extra Items | 6.8B | 8.7B | 12.41B | 6.07B | 10.02B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 24.86 | 31.81 | 45.37 | 22.2 | 36.65 | |||||
Basic EPS - Continuing Operations | 24.86 | 31.81 | 45.37 | 22.2 | 36.65 | |||||
Basic Weighted Average Shares Outstanding | 274M | 274M | 274M | 274M | 273M | |||||
Net EPS - Diluted | 24.86 | 31.81 | 45.37 | 22.2 | 36.65 | |||||
Diluted EPS - Continuing Operations | 24.86 | 31.81 | 45.37 | 22.2 | 36.65 | |||||
Diluted Weighted Average Shares Outstanding | 274M | 274M | 274M | 274M | 273M | |||||
Normalized Basic EPS | 19.51 | 24.69 | 35.56 | 17.36 | 21.05 | |||||
Normalized Diluted EPS | 19.51 | 24.69 | 35.56 | 17.36 | 21.05 | |||||
Dividend Per Share | 8.25 | 10.5 | 15 | 7.5 | - | |||||
Payout Ratio | 28.17 | 44.8 | 23.14 | 67.56 | 20.46 | |||||
American Depositary Receipts Ratio (ADR) | 2 | 2 | 2 | 2 | 2 | |||||
Supplemental Items | ||||||||||
EBITDA | 14.21B | 16.27B | 21.41B | 14.28B | 16.41B | |||||
EBITA | 8.63B | 10.75B | 15.37B | 8.16B | 9.82B | |||||
EBIT | 8.61B | 10.73B | 15.35B | 8.15B | 9.81B | |||||
EBITDAR | 14.75B | 16.83B | 22.25B | 15.42B | 17.56B | |||||
Effective Tax Rate - (Ratio) | 21.54 | 19.7 | 20.45 | 20.08 | 20.14 | |||||
Total Current Taxes | 1.69B | 2.15B | 3.24B | 1.48B | 1.77B | |||||
Total Deferred Taxes | 179M | -18M | -51M | 51M | 758M | |||||
Normalized Net Income | 5.34B | 6.75B | 9.73B | 4.75B | 5.76B | |||||
Interest on Long-Term Debt | 4M | 3M | 4M | 3M | 6M | |||||
Non-Cash Pension Expense | 17M | 12M | 7M | 17M | 24M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 505M | 516M | 651M | 733M | 756M | |||||
General and Administrative Expenses | 675M | 619M | 1.01B | 1.08B | 1.26B | |||||
Research And Development Expense From Footnotes | 749M | 978M | 1.07B | 1.18B | 1.18B | |||||
Net Rental Expense, Total | 537M | 562M | 839M | 1.13B | 1.15B | |||||
Imputed Operating Lease Interest Expense | 84.3M | 86.15M | 194M | 487M | 565M | |||||
Imputed Operating Lease Depreciation | 453M | 476M | 645M | 646M | 585M |
- Stock Market
- Equities
- BOL Stock
- Financials Boliden
- Income Statement
Select your edition
All financial news and data tailored to specific country editions